This field has shown tremendous growth in recent years, primarily due to the recognition that drug-induced liver disease is the most common cause of liver failure and one of the major contributors to the withdrawal of drugs developed by the pharmaceutical industry. Drug-Induced Liver Disease, 3rd edition is a comprehensive reference that covers mechanisms of injury, diagnosis and management, major hepatotoxins, regulatory perspectives and much more. Written by highly respected authorities, this new edition is an updated and definitive reference for clinicians and scientists in academia, the pharmaceutical industry and government settings. This book contains 4 new chapters on key topics in the area and provides a current and extensive review of the latest developments concerning the toxicology, pharmacology, genetics and immunology of drug-induced liver disease. A multi-authored reference work written by leading clinical, academic and industry experts in drug-induced liver disease. Contains four new chapters on key areas in the field, including one on worldwide drug-induced liver injury networks. Each chapter has been updated to address the latest research and findings in the field and 16 new chapter authors have been added to this new edition. Includes coverage of the basic, clinical and practical aspects of drug-induced liver disease to provide the single most comprehensive reference on the subject.... Nucleoside reverse transcriptase inhibitors (NRTIs), 507 Nucleos(t)ide analogs , 512 Nutritions effect on tissue repair, ... fatty liver disease (NAFLD), 268, 729 Nonalcoholic fatty liver injury, 729 Nonalcoholic steatohepatitis (NASH), 88, 92, anbsp;...
|Title||:||Drug-Induced Liver Disease|
|Author||:||Neil Kaplowitz, Laurie D. DeLeve|
|Publisher||:||Academic Press - 2013-04-18|